Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;34(3):183-8.
doi: 10.1002/clc.20894.

NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings

Stefan Toggweiler  1 , Oliver Borst, Frank Enseleit, Matthias Hermann, Frank Ruschitzka, Thomas F Lüscher, Georg Noll
Affiliations

NT-proBNP provides incremental prognostic information in cardiac outpatients with and without echocardiographic findings

Stefan Toggweiler et al. Clin Cardiol. 2011 Mar.

Abstract

Background: Outpatients frequently present with elevated natriuretic peptides in the absence of an obvious cardiac abnormality or with normal natriuretic peptides despite echocardiographic findings.

Hypothesis: We aimed to determine the prognostic value of N-terminal pro B-type natriuretic peptide (NTpBNP) in outpatients with normal and abnormal echocardiography.

Methods: A total of 433 cardiovascular outpatients were included. The prognostic value of NTpBNP in patients with normal and abnormal echocardiography during a 2-year follow-up was evaluated.

Results: Patients with abnormal echocardiography and elevated NTpBNP had a mortality rate of 8.7% and an overall event rate of 20.2% (composite end point of overall mortality, myocardial infarction, and hospitalization for heart failure), which was significantly higher than in patients with abnormal echocardiography and normal NTpBNP, in which no mortality (P=0.011) and no events were observed (P<0.001). In patients with a normal echocardiography, mortality was 1.5% and 1.8% for patients with normal and elevated NTpBNP, respectively (P=1.000). Composite event rate was 1.5% and 8.9% (P=0.093), respectively.

Conclusions: Patients with low NTpBNP have an excellent prognosis irrespective of echocardiographic findings. Therefore, determination of NTpBNP appears useful in assessing the clinical relevance of echocardiographic findings.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Event‐free survival in relation to N‐terminal pro B‐type natriuretic peptide (NTpBNP) and echocardiographic results (A), and in relation to NTpBNP and New York Heart Association (NYHA) class (B). Kaplan‐Meier curves are shown for patients with normal and abnormal echocardiography and normal and elevated NTpBNP (A), and for patients in NYHA class I and NYHA class >I and normal and elevated NTpBNP (B). P values indicate overall log‐rank comparison. Events are all‐cause mortality, myocardial infarction, and hospitalization for heart failure.
See this image and copyright information in PMC

References

    1. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left‐ventricular systolic dysfunction. Lancet. 1998;351:9–13. - PubMed
    1. Mottram PM, Leano R, Marwick TH. Usefulness of B‐type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol. 2003;92:1434–1438. - PubMed
    1. Mueller C, Breithardt T, Laule‐Kilian K, et al. The integration of BNP and NT‐proBNP into clinical medicine. Swiss Med Wkly. 2007;137:4–12. - PubMed
    1. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B‐type natriuretic peptide in comparison with those of A‐type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203. - PubMed
    1. Mueller C, Scholer A, Laule‐Kilian K, et al. Use of B‐type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647–654. - PubMed

Substances